MARKET

AORT

AORT

Artivion, Inc.
NYSE
20.57
+0.30
+1.48%
After Hours: 20.57 0 0.00% 16:20 04/26 EDT
OPEN
20.24
PREV CLOSE
20.27
HIGH
20.60
LOW
20.24
VOLUME
85.90K
TURNOVER
0
52 WEEK HIGH
21.90
52 WEEK LOW
12.16
MARKET CAP
857.97M
P/E (TTM)
-27.4194
1D
5D
1M
3M
1Y
5Y
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Artivion's first quarter 2024 financial results will be released on May 6, 2024 after the market closes. The Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results. Artivion is a leading cardiac and vascular surgery company focused on aortic disease.
PR Newswire · 4d ago
Weekly Report: what happened at AORT last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at AORT last week (0408-0412)?
Weekly Report · 04/15 09:21
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
Artivion Is Maintained at Buy by Needham
Dow Jones · 04/08 18:44
Artivion Price Target Maintained With a $25.00/Share by Needham
Dow Jones · 04/08 18:44
Needham Maintains Buy on Artivion, Maintains $25 Price Target
Benzinga · 04/08 18:35
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
TipRanks · 04/08 18:15
More
About AORT
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.